alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Editorial Note on Part 892
Editorial Note: Nomenclature changes to part 892 appear at 73 FR 35341, June 23, 2008.

§ 892.3 Effective dates of requirement for premarket approval. A device included in this part that is classified into class III (premarket approval) shall not be commercially distributed after the date shown in the regulation classifying the device unless the manufacturer has an approval under section 515 of the act (unless an exemption has been granted under section 520(g)(2) of the act). An approval under section 515 of the act consists of FDA's issuance of an order approving an application for premarket approval (PMA) for the device or declaring completed a product development protocol (PDP) for the device. ( a ) Before FDA requires that a device commercially distributed before the enactment date of the amendments, or a device that has been found substantially equivalent to such a device, has an approval under section 515 of the act, FDA must promulgate a regulation under section 515(b) of the act requiring such approval, except as provided in paragraph (b) of this section. Such a regulation under section 515(b) of the act shall not be effective during the grace period ending on the 90th day after its promulgation or on the last day of the 30th full calendar month after the regulation that classifies the device into class III is effective, whichever is later. See section 501(f)(2)(B) of the act. Accordingly, unless an effective date of the requirement for premarket approval is shown in the regulation for a device classified into class III in this part, the device may be commercially distributed without FDA's issuance of an order approving a PMA or declaring completed a PDP for the device. If FDA promulgates a regulation under section 515(b) of the act requiring premarket approval for a device, section 501(f)(1)(A) of the act applies to the device.
( b ) Any new, not substantially equivalent, device introduced into commercial distribution on or after May 28, 1976, including a device formerly marketed that has been substantially altered, is classified by statute (section 513(f) of the act) into class III without any grace period and FDA must have issued an order approving a PMA or declaring completed a PDP for the device before the device is commercially distributed unless it is reclassified. If FDA knows that a device being commercially distributed may be a “new” device as defined in this section because of any new intended use or other reasons, FDA may codify the statutory classification of the device into class III for such new use. Accordingly, the regulation for such a class III device states that as of the enactment date of the amendments, May 28, 1976, the device must have an approval under section 515 of the act before commercial distribution.
TEXAS COURT OF APPEALS, THIRD DISTRICT, AT AUSTIN

JUDGMENT RENDERED FEBRUARY 16, 2024

NO. 03-22-00736-CV

Sarah Cook, Appellant

v.

Texas Highway Walls, LLC, Appellee

APPEAL FROM THE 201ST DISTRICT COURT OF TRAVIS COUNTY

BEFORE CHIEF JUSTICE BYRNE, JUSTICES TRIANA AND THEOFANIS

AFFIRMED IN PART, REVERSED AND REMANDED IN PART –

OPINION BY CHIEF JUSTICE BYRNE

CONCURRING AND DISSENTING OPINION BY JUSTICE THEOFANIS

This is an appeal from the order signed by the trial court on October 24, 2022. Having reviewed 

the record and the parties’ arguments, the Court holds that there was reversible error in the 

court’s order. Therefore, the Court affirms in part and reverses the trial court’s order and 

remands the case to the trial court for further proceedings consistent with the Court’s opinion. 

Each party shall bear its own costs relating to this appeal, both in this Court and in the 

court below.
GILBERT WASHINGTON,

Appellant,

v.

SCHOOL DISTRICT OF 

HILLSBOROUGH COUNTY 

AND BROADSPIRE,

Appellees.

IN THE DISTRICT COURT OF APPEAL

FIRST DISTRICT, STATE OF FLORIDA

NOT FINAL UNTIL TIME EXPIRES TO 

FILE MOTION FOR REHEARING AND 

DISPOSITION THEREOF IF FILED

CASE NO. 1D14-248

_____________________________/

Opinion filed January 13, 2015.

An appeal from an order of the Judge of Compensation Claims.

Stephen L. Rosen, Judge.

Dates of Accidents: April 23, 2007; July 25, 2007.

Gilbert Washington, pro se.

Robert P. Byelick and Allison G. Mawhinney of Abbey, Adams, Byelick & Mueller, 

L.L.P., St. Petersburg, for Appellees.

PER CURIAM.

AFFIRMED.

WOLF, RAY, and MAKAR, JJ., CONCUR.
| (logo) WELLS FARGO | **Corporate Trust Services**MAC R1204-0109062 Old Annapolis RoadColumbia, MD 21045Tel: 410 884 2000 Fax: 410 715 2380 |
|--------------------|-----------------------------------------------------------------------------------------------------------------------|

 

 

RE: Annual Statement of Compliance for Credit Suisse First Boston Mortgage Securities Corp., Commercial Mortgage Pass-Through Certificates Series 2015-C3

 

Per the Pooling and Servicing Agreement dated as of August 1, 2015 (the "Agreement"), the undersigned, a duly authorized officer of Wells Fargo Bank, N.A., as Certificate Administrator ("Wells Fargo"), hereby certifies as follows as of and for the year ending December 31, 2015 (the "Reporting Period"):

 

(a) A review of Wells Fargo's activities during the Reporting Period and of its performance under the Agreement has been made under such officer's supervision; and

 

(b) To the best of such officer's knowledge, based on such review, Wells Fargo has fulfilled all of its obligations under the Agreement in all material respects throughout the Reporting Period.

 

 

March 1, 2016

 

/s/ Brian Smith

BRIAN SMITH

Vice President

 

 

Wells Fargo Bank, N.A.
```

[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 8000 Introduced in House (IH)]

<DOC>

118th CONGRESS
  2d Session
                                H. R. 8000

 To limit closures and consolidations of United States Postal Service 
          mail processing facilities, and for other purposes.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                             April 15, 2024

   Mr. Golden of Maine (for himself and Mr. Pfluger) introduced the 
 following bill; which was referred to the Committee on Oversight and 
                             Accountability

_______________________________________________________________________

                                 A BILL

 
 To limit closures and consolidations of United States Postal Service 
          mail processing facilities, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Timely Mail Delivery and Postal 
Services Protection Act''.

SEC. 2. LIMITATION ON CLOSURE AND CONSOLIDATION OF MAIL PROCESSING 
              FACILITIES.

    (a) Prohibiting on Carrying Out Mail Processing Facility Review.--
Notwithstanding any other provision of law, the United States Postal 
Service may not carry out the United States Postal Service Mail 
Processing Facility Review (or any successor program), and no Federal 
funds (including amounts in the Postal Service Fund under section 2003 
of title 39, United States Code) may be obligated or expended to carry 
out such Review.
    (b) Limitation on Changes to Mail Processing Facilities.--
            (1) In general.--Notwithstanding any other provision of 
        law, the Postal Service may not implement or otherwise carry 
        out any changes to the operations of its mail processing 
        facilities (including consolidation or partial consolidation, 
        aggregation of processing, distribution, or delivery 
        operations) until on or after the date that the Postal 
        Regulatory Commission issues an advisory opinion on the 
        proposed facility changes.
            (2) Deadline.--The Postal Regulatory Commission shall issue 
        the advisory opinion required under paragraph (1) not later 
        than 120 business days after the date the Postal Service 
        submits to the Commission a proposed change to any such 
        facility.
                                 <all>
```
§ 1.381(c)(18)-1 Depletion on extraction of ores or minerals from the waste or residue of prior mining. ( a ) *Carryover requirement.* Section 381(c)(18) provides that the acquiring corporation in a transaction described in section 381(a) shall be considered as though it were the distributor or transferor corporation after the date of distribution or transfer for the purpose of determining the applicability of section 613(c)(3) (relating to extraction of ores or minerals from the ground). Thus, an acquiring corporation which has acquired the waste or residue of prior mining from a distributor or transferor corporation in a transaction described in section 381(a) shall be entitled, after the date of distribution or transfer, to an allowance for depletion under section 611 in respect of ores or minerals extracted from such waste or residue if the distributor or transferor corporation would have been entitled to such an allowance for depletion in the absence of the distribution or transfer. See paragraph (f) of § 1.613-4 to determine whether a distributor or transferor corporation is entitled to an allowance for depletion with respect to the waste or residue of prior mining.
( b ) *Application of section 614 to waste or residue of prior mining.* If, in a transaction described in section 381(a), the acquiring corporation acquires waste or residue of prior mining from a distributor or transferor corporation, then the acquiring corporation shall be considered as though it were the distributor or transferor corporation for the purpose of applying section 614 and the regulations thereunder to the waste or residue so acquired. Thus, if the distributor or transferor corporation was required under paragraph (c) of § 1.614-1 to treat the waste or residue as part of the mineral deposit from which it was extracted and if the acquiring corporation acquires both the waste or residue and the mineral deposit from which it was extracted in a transaction described in section 381(a), then such waste or residue shall be treated as a part of such mineral deposit in the hands of the acquiring corporation. On the other hand, if the waste or residue was required to be treated as a separate mineral deposit in the hands of the distributor or transferor corporation, such waste or residue shall be treated as a separate mineral deposit in the hands of the acquiring corporation.
[T.D. 6552, 26 FR 1991, Mar. 8, 1961, as amended by T.D. 7170, 37 FR 5373, Mar. 15, 1972]
UNPUBLISHED

UNITED STATES COURT OF APPEALS

FOR THE FOURTH CIRCUIT

No. 23-1769

MEIBY LISBETH DUBON HERNANDEZ,

Petitioner,

v.

MERRICK B. GARLAND, Attorney General,

Respondent.

On Petition for Review of an Order of the Board of Immigration Appeals. 

Submitted: May 30, 2024 Decided: June 3, 2024

Before GREGORY and HARRIS, Circuit Judges, and MOTZ, Senior Circuit Judge.

Petition denied by unpublished per curiam opinion.

ON BRIEF: Ivan Yacub, YACUB LAW OFFICES, LLC, Woodbridge, Virginia, for 

Petitioner. Brian Boynton, Principal Deputy Assistant Attorney General, Cindy S. Ferrier, 

Assistant Director, Micah Engler, Office of Immigration Litigation, Civil Division, 

UNITED STATES DEPARTMENT OF JUSTICE, Washington, D.C., for Respondent. 

Unpublished opinions are not binding precedent in this circuit.

USCA4 Appeal: 23-1769 Doc: 32 Filed: 06/03/2024 Pg: 1 of 3
2

PER CURIAM:

Meiby Lisbeth Dubon Hernandez, a native and citizen of El Salvador, petitions for 

review of the Board of Immigration Appeals’ order denying Dubon Hernandez’s motion 

to reopen her removal proceedings. We review the denial of a motion to reopen for abuse 

of discretion. Lawrence v. Lynch, 826 F.3d 198, 203 (4th Cir. 2016); 8 C.F.R. § 1003.2(a), 

(c). The “denial of a motion to reopen is reviewed with extreme deference, given that 

motions to reopen are disfavored because every delay works to the advantage of the 

deportable [noncitizen] who wishes merely to remain in the United States.” Sadhvani v. 

Holder, 596 F.3d 180, 182 (4th Cir. 2009) (internal quotation marks omitted). 

We have reviewed the Board’s order, in conjunction with the administrative record 

and relevant authorities, and conclude that the Board did not abuse its discretion in holding 

that Dubon Hernandez failed to substantially comply with the third requirement identified 

in In re Lozada, 19 I. & N. Dec. 637 (B.I.A. 1988), and denying the motion on this basis, 

see Barry v. Gonzales, 445 F.3d 741, 745-47 (4th Cir. 2006) (discussing Lozada

requirements and explaining that this court will “only review the merits of the [Board’s] 

denial of a motion to reopen on the basis of ineffective assistance of counsel where the 

[noncitizen] has complied with” those requirements). Nor do we discern any abuse of 

discretion in the Board’s additional finding that Dubon Hernandez did not demonstrate 

prejudice flowing from her former attorney’s alleged ineffective representation. See In re 

Melgar, 28 I. & N. Dec. 169, 171 (B.I.A. 2020) (discussing prejudice requirement for 

reopening based on an attorney’s alleged ineffective representation). 

USCA4 Appeal: 23-1769 Doc: 32 Filed: 06/03/2024 Pg: 2 of 3
3

Accordingly, we deny the petition for review. See In re Dubon Hernandez (B.I.A. 

July 10, 2023). We dispense with oral argument because the facts and legal contentions 

are adequately presented in the materials before this court and argument would not aid the 

decisional process.

PETITION DENIED

USCA4 Appeal: 23-1769 Doc: 32 Filed: 06/03/2024 Pg: 3 of 3
To: Joe Hagerman

From: Lois Starkey

Date: February 23, 2015

Subject: MHI Winter Meeting

On behalf of the Manufactured Housing Institute, thank you for attending the MHI Winter Meeting,

February 9, 2015. It was a timely opportunity for MHI’s leadership and members to hear from you

regarding the recommendations of the Department of Energy’s ASRAC Working Group on Manufactured

Housing, including a summary of the term sheet developed by the Working Group and the non

‐ binding

recommendations.

It was also helpful to hear the status of the Department’s plans to propose rulemaking to implement the

2007 Congressional mandate to establish energy efficiency standards for manufactured housing, and to

hear of DOE’s support of a recommendation by the consensus group to establish another ASRAC

Working Group to address compliance and enforcement of the energy efficiency standards.

Again, thank you for taking the time to attend our meeting. Your participation and presentation were

well received and much appreciated.
```

[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 8123 Introduced in House (IH)]

<DOC>

118th CONGRESS
  2d Session
                                H. R. 8123

  To amend the Federal Food, Drug, and Cosmetic Act to establish new 
            prohibited acts relating to dietary supplements.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                             April 23, 2024

 Mr. Pallone introduced the following bill; which was referred to the 
                    Committee on Energy and Commerce

_______________________________________________________________________

                                 A BILL

 
  To amend the Federal Food, Drug, and Cosmetic Act to establish new 
            prohibited acts relating to dietary supplements.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. NEW PROHIBITED ACTS RELATING TO DIETARY SUPPLEMENTS.

    (a) In General.--Section 301 of the Federal Food, Drug, and 
Cosmetic Act (21 U.S.C. 331) is amended by adding at the end the 
following:
    ``(jjj) The introduction or delivery for introduction into 
interstate commerce of any product marketed as a dietary supplement 
that does not meet the definition of a dietary supplement under section 
201(ff).
    ``(kkk) The introduction or delivery for introduction into 
interstate commerce of a dietary supplement that has been prepared, 
packed, or held using the assistance of, or at the direction of, a 
person debarred under section 306.''.
    (b) New Import Exclusion.--Section 801(a) of the Federal Food, 
Drug, and Cosmetic Act (21 U.S.C. 381(a)) is amended in paragraph (3) 
of the third sentence, by striking ``section 301(ll)'' and inserting 
``paragraph (ll), (jjj), or (kkk) of section 301''.
    (c) New Seizure Authorities.--Section 304 of the Federal Food, 
Drug, and Cosmetic Act (21 U.S.C. 334) is amended--
            (1) in subsection (a)(1), in the first sentence, by 
        striking ``section 301(ll)'' and inserting ``paragraph (ll), 
        (jjj), or (kkk) of section 301''; and
            (2) in subsection (d)(1), in the first sentence, by 
        striking ``or cosmetic'' and inserting ``cosmetic, or product 
        in violation of paragraph (jjj) or (kkk) of section 301''.
                                 <all>
```
<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
     (Replace this text with the legend)
</LEGEND>
<CIK>                         0000854860
<NAME>                        Williams Controlsm Inc.
<MULTIPLIER>                                   1,000
<CURRENCY>                                     U.S. Dollars
       
<S>                                            <C>
<PERIOD-TYPE>                                  9-MOS
<FISCAL-YEAR-END>                              Sep-30-1996
<PERIOD-START>                                 Oct-01-1995
<PERIOD-END>                                   Jun-30-1996
<EXCHANGE-RATE>                                     1
<CASH>                                          1,379
<SECURITIES>                                        0
<RECEIVABLES>                                  13,548
<ALLOWANCES>                                     (445)
<INVENTORY>                                    15,288
<CURRENT-ASSETS>                               31,655
<PP&E>                                         24,955
<DEPRECIATION>                                  5,154
<TOTAL-ASSETS>                                 53,778
<CURRENT-LIABILITIES>                          29,600
<BONDS>                                             0
<PREFERRED-MANDATORY>                               0
<PREFERRED>                                         0
<COMMON>                                          179
<OTHER-SE>                                     17,831
<TOTAL-LIABILITY-AND-EQUITY>                   53,778
<SALES>                                        38,116
<TOTAL-REVENUES>                               38,116
<CGS>                                          26,921
<TOTAL-COSTS>                                  32,407
<OTHER-EXPENSES>                                   75
<LOSS-PROVISION>                                    0
<INTEREST-EXPENSE>                              1,154
<INCOME-PRETAX>                                 4,480
<INCOME-TAX>                                    1,760
<INCOME-CONTINUING>                             2,720
<DISCONTINUED>                                 (2,220)
<EXTRAORDINARY>                                     0
<CHANGES>                                           0
<NET-INCOME>                                      410
<EPS-PRIMARY>                                     .02
<EPS-DILUTED>                                     .02
        




</TABLE>
# Official Journal L 179/2020

| | ISSN 1977-0677 |
| --- | --- |
| Official Journal
  of the European Union | L 179 |
| | |
| English edition | Legislation | Volume 639 June 2020 |

ISSN 1977-0677

Official Journal

of the European Union

L 179

English edition

Legislation

Volume 639 June 2020

---

| Contents | | II   Non-legislative acts | page |
| --- | --- | --- | --- |
| | | REGULATIONS |
| | * | Commission Delegated Regulation (EU) 2020/756 of 1 April 2020 amending Annexes II and III to Regulation (EU) No 1307/2013 of the European Parliament and of the Council | 1 |
| | * | Commission Regulation (EU) 2020/757 of 8 June 2020 amending Regulation (EU) No 142/2011 as regards the traceability of certain animal by-products and derived products (
  1
  ) | 5 |
| | | DECISIONS |
| | * | Commission Implementing Decision (EU) 2020/758 of 4 June 2020 on measures to be taken by the United Kingdom concerning Xylella fastidiosa and Ceratocystis platani

  (notified under document C(2020) 3604) | 8 |
| | * | Commission Implementing Decision (EU) 2020/759 of 8 June 2020 amending Implementing Decision (EU) 2016/588 in order to include the use of 12 Volt efficient alternators in passenger cars capable of running on certain alternative fuels (
  1
  ) | 13 |

Contents

II   Non-legislative acts

page

REGULATIONS

*

Commission Delegated Regulation (EU) 2020/756 of 1 April 2020 amending Annexes II and III to Regulation (EU) No 1307/2013 of the European Parliament and of the Council

1

*

Commission Regulation (EU) 2020/757 of 8 June 2020 amending Regulation (EU) No 142/2011 as regards the traceability of certain animal by-products and derived products (
  1
  )

1

5

DECISIONS

*

Commission Implementing Decision (EU) 2020/758 of 4 June 2020 on measures to be taken by the United Kingdom concerning Xylella fastidiosa and Ceratocystis platani

  (notified under document C(2020) 3604)

Xylella fastidiosa

Ceratocystis platani

(notified under document C(2020) 3604)

8

*

Commission Implementing Decision (EU) 2020/759 of 8 June 2020 amending Implementing Decision (EU) 2016/588 in order to include the use of 12 Volt efficient alternators in passenger cars capable of running on certain alternative fuels (
  1
  )

1

13

| | |
| --- | --- |
| | (1)   Text with EEA relevance. |

---

(1)   Text with EEA relevance.

| EN | Acts whose titles are printed in light type are those relating to day-to-day management of agricultural matters, and are generally valid for a limited period.
  The titles of all other Acts are printed in bold type and preceded by an asterisk. |
| --- | --- |

EN

Acts whose titles are printed in light type are those relating to day-to-day management of agricultural matters, and are generally valid for a limited period.

The titles of all other Acts are printed in bold type and preceded by an asterisk.